Chugai Pharmaceutical Co Stock Today
| CHGCY Stock | USD 21.57 0.74 3.55% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Chugai Pharmaceutical is trading at 21.57 as of the 28th of November 2024; that is 3.55% increase since the beginning of the trading day. The stock's open price was 20.83. Chugai Pharmaceutical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on July 9, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Chugai Pharmaceutical's common stock.
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd. The company has 3.29 B outstanding shares. More on Chugai Pharmaceutical Co
Moving together with Chugai Pink Sheet
| 0.72 | LLY | Eli Lilly Sell-off Trend | PairCorr |
| 0.74 | RHHBF | Roche Holding AG | PairCorr |
| 0.78 | RHHBY | Roche Holding | PairCorr |
| 0.77 | RHHVF | Roche Holding AG | PairCorr |
Moving against Chugai Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Chugai Pink Sheet Highlights
| Thematic Idea | Cash Cows (View all Themes) |
| Business Concentration | Cash Cows, Drug Manufacturers—General, Healthcare (View all Sectors) |
Chugai Pharmaceutical Co [CHGCY] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 44.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Chugai Pharmaceutical's market, we take the total number of its shares issued and multiply it by Chugai Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Chugai Pharmaceutical classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 3.29 B outstanding shares.
Chugai Pharmaceutical Co has accumulated about 545.3 B in cash with 279.63 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 165.74, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Chugai Pharmaceutical Probability Of Bankruptcy
Chugai Pharmaceutical Risk Profiles
| Mean Deviation | 1.81 | |||
| Standard Deviation | 2.53 | |||
| Variance | 6.42 | |||
| Risk Adjusted Performance | (0.05) |
Chugai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Chugai Pharmaceutical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Chugai Pharmaceutical Corporate Directors
| Shinji Hidaka | Executive Officer, Deputy Chief Director of Sales, Manager of Primary Unit | Profile | |
| Osamu Okuda | Executive Officer, Director of Business Planning | Profile | |
| Yoshiaki Ohashi | Executive Officer, Chief Director of Drug Safety, Manager of Regulatory & Quality Management Unit | Profile | |
| Tetsuya Yamaguchi | Executive Officer, Director of Business Development | Profile |
Additional Tools for Chugai Pink Sheet Analysis
When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.